Nov. 30, 2021 — Pfizer and BioNTech plan to use for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.
“We count on to share updates on this quickly,” Package Longley, a Pfizer spokesman, advised The Washington Submit.
The FDA may authorize the additional dose inside per week. If permitted, the extra shot could be the primary booster permitted for these below age 18.
“Given the present total state of affairs of the pandemic, FDA will consider any such [emergency use authorization] request in a really well timed method,” the company advised the newspaper.
As nations around the globe transfer to handle the brand new Omicron variant, well being officers have known as on folks to get vaccinated — and for absolutely vaccinated folks to get their booster pictures. On Monday, President Joe Biden known as the vaccines “one of the best safety towards this new variant or any of the variants on the market.”
The Omicron variant hasn’t but been detected within the U.S., although Biden administration officers have mentioned in latest days that it’s anticipated to unfold across the globe. As of Tuesday morning, 14 nations had reported greater than 180 instances to GISAID, a worldwide database for the genomic sequencing of viruses.
Federal regulators have cited latest knowledge from Israel on booster pictures as reassurance for authorizing booster doses for 16- and 17-year-olds, the newspaper reported. The research have proven that critical unwanted effects for youthful folks have been unusual and gentle.
Extending the age vary for booster pictures “earlier than Omicron hits can probably assist and definitely gained’t harm,” Jeanne Marrazzo, MD, an infectious illness physician on the College of Alabama at Birmingham, advised the Submit.
On Nov. 19, the FDA approved booster pictures of the Pfizer and Moderna vaccines for folks ages 18 and older. All adults who acquired the one-shot Johnson & Johnson vaccine are additionally eligible for a booster.